What is the Impact Factor of Ebiomedicine?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Ebiomedicine is 11.2, ranking in quartile Q1 of Web of Science (SCIE).

Is Ebiomedicine indexed in Web of Science or Scopus?

Yes, Ebiomedicine is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 3.742 (Q1) and an H-index of 156.

Who publishes Ebiomedicine and what is the Article Processing Charge (APC)?

Ebiomedicine is published by Elsevier BV. The estimated Article Processing Charge (APC) is approximately $4,130 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Ebiomedicine?

The official ISO-4 abbreviation of Ebiomedicine is "EBIOMEDICINE" with common acronym "ebiom". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #483Top JournalGold OA

Ebiomedicine

Acronym:ebiom

•

Abbreviation (ISO):EBIOMEDICINE

•

Identifier (ISSN):2352-3964(Print)

•

Publisher:Elsevier BV

Official Website Submission Portal Compare

Clarivate IF (2026)

11.2↑ +0.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Ebiomedicine

WoS Q1

Annual Impact Factor Metric

Current (2026):11.2

Scopus SJR & RankScopus Q1

3.742

#483

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

156

156 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

380articles/year

100% Gold OA•87.45% Original Research

Aims & Scope

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

Topics Covered (Recognized by AI)

MedicineBiologyGeneticsInternal MedicineChemistryBiochemistryPathologyImmunologyEndocrinologyCancer ResearchPsychologyBioinformaticsOncology & Cancer ResearchSurgeryCell Biology

Primary Research Areas

Biochemistry Genetics and Molecular Biology General Biochemistry

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank19/191

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank8/191

IndexSCIE

Category	Index	Rank	Quartile
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	19/191	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	8/191	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF11.2

Articles / Year377

Total Citations282

2025

IF10.8

Articles / Year548

Total Citations4,176

2024

IF9.7

Articles / Year586

Total Citations11,026

2023

IF11.1

Articles / Year508

Total Citations18,103

2022

IF11.205

Articles / Year617

Total Citations26,485

Year	Impact Factor	Articles / Year	Total Citations
2026	11.2	377	282
2025	10.8	548	4,176
2024	9.7	586	11,026
2023	11.1	508	18,103
2022	11.205	617	26,485
2021	8.143	614	25,635
2020	5.736	580	32,759
2019	6.68	727	40,828
2018	6.183	539	31,917
2017	—	402	22,570
2016	—	477	28,583
2015	—	375	16,339

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #483Scopus Q1SCImago Profile

Scopus Coverage:2014-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

3.742

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

10.22

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,130 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations17,265

3-Year Documents1,673

Citable Documents1,439

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)7

Citations in government and international policy documents

Female Author Rate44.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1

Medicine (miscellaneous)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区MEDICINE, RESEARCH & EXPERIMENTAL

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Ebiomedicine (acronym: ebiom, abbr: EBIOMEDICINE, ISSN: 2352-3964) is a peer-reviewed international scholarly journal in the field of Biochemistry, published by Elsevier BV in Netherlands. The periodical holds a Journal Impact Factor (JIF) of 11.2, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.742 (Q1), an H-index of 156.

The journal enforces rigorous peer evaluation with an annual output of approximately 380 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,130 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.